Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety and efficacy of aztreonam for inhalation
solution (AZLI) in patients with cystic fibrosis (CF) and lung infection due to Pseudomonas
aeruginosa (PA).